ASCF(SH:600855)2023-03-20 16:00Financial Performance - The net profit attributable to the parent company for 2022 was CNY 5,477,761.49, with a cumulative profit available for distribution to shareholders at CNY 105,489,616.30[5]. - The company reported a revenue of 1.802 billion RMB in 2022, a decrease of 35.30% compared to 2.785 billion RMB in 2021[28]. - Net profit attributable to shareholders was 0.055 billion RMB, down 95.33% from 0.117 billion RMB in the previous year[28]. - The basic earnings per share decreased to 0.0125 RMB, a decline of 95.33% from 0.2677 RMB in 2021[27]. - The total assets decreased by 8.32% to 4.021 billion RMB from 4.386 billion RMB in 2021[26]. - The company achieved an annual revenue of 1.802 billion RMB and a net profit attributable to shareholders of 5.5 million RMB in 2022[38]. - The company achieved operating revenue of 1.802 billion RMB, a decrease of 35.30% compared to the previous year[48]. - Net profit for the period was 32 million RMB, with net profit attributable to shareholders of 5.5 million RMB[48]. Business Segments and Strategy - The company has restructured its main business segments into three major areas: high-end medical equipment, military electronics, and public safety, aiming to enhance resource collaboration and optimize industry layout[9]. - The company emphasizes high-quality development and focuses on core industries, aiming to strengthen its core competitiveness, marketing capabilities, and profitability[9]. - The high-end medical equipment sector saw a revenue decline of 78.16% and a net profit drop of 142.78% compared to the previous year[28]. - The military electronics sector's revenue decreased by 2.47%, with net profit declining by 34.73%[28]. - The public safety sector's revenue fell by 47.83%, while net profit increased by 103.02% due to improved asset quality management[28]. - The company is positioned in the high-end medical equipment, military electronics, and public safety sectors, benefiting from supportive policies and market demand[41]. - The company is focusing on expanding its market presence in the domestic military electronics sector and enhancing collaboration with key research institutions[38]. Research and Development - The company plans to increase investment in R&D for key products like high-end domestic ventilators and ECMO systems to enhance market competitiveness[28]. - The company completed 102 invention patent applications and received 4 provincial and ministerial-level science and technology progress awards during the year[39]. - The company is advancing the ECMO system research and development project and has successfully launched upgraded ventilator products[39]. - The company is enhancing its digital capabilities by promoting digital manufacturing for high-end medical devices and developing a series of controllable digital software products[40]. - Total R&D investment amounted to ¥116,158,424.56, representing 6.45% of operating income[66]. - The number of R&D personnel accounted for 22.65% of the total workforce[66]. - Research and development expenses fell by 25.17% to 112.76 million RMB, as new projects had just commenced and had not yet entered a high investment phase[51]. Governance and Compliance - The company has received a standard unqualified audit report from its accounting firm, Zhihong[4]. - The company has committed to ensuring the authenticity, accuracy, and completeness of the annual report, with all board members present at the meeting[4]. - The company has optimized its governance structure and completed the establishment of necessary party organizations and board systems across subsidiaries[40]. - The company has established a long-term mechanism for internal control, conducting annual audits and evaluations of control deficiencies[138]. - The company has implemented a comprehensive internal control system covering all business areas, with subsidiaries establishing risk control committees and management systems[138]. - The company has strengthened its compliance governance system, ensuring that major operational decisions are effectively monitored and controlled[140]. Shareholder and Management Information - The total number of shares held by the board members at the end of the reporting period remained unchanged at 1,075,100 shares[105]. - The total pre-tax remuneration for the board members during the reporting period amounted to 5.71 million yuan[105]. - The chairman, Xiao Haichao, received a total pre-tax remuneration of 712,100 yuan[105]. - The president, Su Zihua, received a total pre-tax remuneration of 851,300 yuan[105]. - The company appointed new executives, including a female vice president and a female CFO, both starting their terms in January 2023[105]. - The company has a structured approach to governance, ensuring compliance with relevant laws and regulations[102]. Environmental and Social Responsibility - The company invested 50 million yuan in environmental protection during the reporting period[144]. - The company processed a total of 3.5 tons of hazardous waste in 2022, primarily from packaging and cleaning operations[144]. - The company reduced carbon emissions by 53 tons through various measures, including the promotion of photovoltaic technology and the use of energy-efficient equipment[148]. - The distributed photovoltaic power station generated approximately 32,400 kWh in 2022, leading to a reduction of about 10 tons of CO2 emissions[149]. - The company donated CNY 15,000 to a local charity, benefiting 10 individuals[150]. Legal and Financial Matters - The company is involved in a significant lawsuit with ongoing developments, including a mediation agreement confirming payments and obligations[168]. - The company reported actual sales-related related party transactions of 95.2098 million yuan, which is 31.74% of the projected 300 million yuan[171]. - The company has a financial relationship with the financial company of the controlling group, with a total credit of 90 million yuan and an actual occurrence of 0.038021 million yuan[177]. - The company reported a total deposit amount of 789.6518 million yuan with a range of interest rates from 0.35% to 1.95%[175]. - The company has established a financial cooperation agreement with the Aerospace Science and Industry Financial Company, which includes various financial services[178].